ArticleBreast cancer research : BCR2022

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers.

Elise Ballot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.